The new standards, which forms a part of the NHS’s maternal care bundle, has been developed by frontline clinicians, women and families, Royal Colleges, regulatory bodies, professional societies and charities
NICE analysis found that introducing SGLT-2 medicines earlier in the treatment pathway helps reduce the risk of heart attacks, strokes and kidney problems
